Molecular Pathology Research Project of Glioma

NCT04924127 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 976

Last updated 2023-04-19

No results posted yet for this study

Summary

Evaluate the diagnostic value of TERT promoter mutation in differ glioma subtypes and expend the application of the diagnostic algorithm to surgical practice

Conditions

  • Glioma, Malignant

Interventions

DIAGNOSTIC_TEST

Detection of IDH and TERT mutation

Detection of IDH and TERT mutation using frozen glioma tissues

Sponsors & Collaborators

  • Jinsong Wu

    lead OTHER

Principal Investigators

  • Jin-song Wu, MD & PhD · Huashan Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-05
Primary Completion
2021-06-06
Completion
2021-12-20

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04924127 on ClinicalTrials.gov